Page last updated: 2024-10-28

hexamethonium and Blood Pressure, High

hexamethonium has been researched along with Blood Pressure, High in 275 studies

Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

Research Excerpts

ExcerptRelevanceReference
"This study aimed to evaluate whether exercise training could contribute to a better modulation of the neurohumoral mechanisms linked to the pathophysiology of arterial hypertension (AH) in postmenopausal hypertensive rats treated with hydrochlorothiazide (HCTZ)."8.31Concurrent exercise training induces additional benefits to hydrochlorothiazide: Evidence for an improvement of autonomic control and oxidative stress in a model of hypertension and postmenopause. ( Bernardes, N; da Silva Dias, D; De Angelis, K; Ferreira, MJ; Irigoyen, MC; Santos Ferreira Silva, MPD, 2023)
"Many studies have implicated both angiotensin II (ANG II) and aldosterone (Aldo) in the pathogenesis of hypertension, the progression of renal injury, and cardiac remodeling after myocardial infarction."7.77Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension. ( Beltz, TG; Gomez-Sanchez, CE; Guo, F; Hay, M; Johnson, AK; Xue, B; Yu, Y, 2011)
"This study was conducted to examine if central amiloride-sensitive transport systems are involved in the development and/or maintenance of hypertension in spontaneously hypertensive rats (SHR)."7.71Contribution of central amiloride-sensitive transport systems to the development of hypertension in spontaneously hypertensive rats. ( Akahoshi, M; Kitamura, S; Nagao, S; Nonaka, M; Seto, S; Yano, K, 2001)
"To explore the pathophysiological role of leptin in obesity-related hypertension, we examined cardiovascular phenotypes of transgenic skinny mice whose elevated plasma leptin concentrations are comparable to those seen in obese subjects."7.70Pathophysiological role of leptin in obesity-related hypertension. ( Aizawa-Abe, M; Ebihara, K; Hayashi, T; Hosoda, K; Inoue, G; Iwai, H; Masuzaki, H; Matsuoka, N; Nakao, K; Ogawa, Y; Satoh, N; Yoshimasa, Y, 2000)
"The purpose of the present study was to identify mechanisms that contribute to increased venous smooth muscle tone in desoxycorticosterone acetate (DOCA)-salt hypertension in rats."7.70Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension. ( Fink, GD; Galligan, JJ; Johnson, RJ, 2000)
" To investigate the mechanisms by which bupivacaine may act within the CNS to produce cardiovascular toxicity, we studied four groups of halothane-anesthetized rabbits in which infusion of intracerebroventricular (icv) bupivacaine or intravenous (iv) phenylephrine resulted in dysrhythmias and hypertension."7.68Hexamethonium and midazolam terminate dysrhythmias and hypertension caused by intracerebroventricular bupivacaine in rabbits. ( Artu, AA; Bernards, CM, 1991)
"The objective of this study was to determine if ablation of the lateral parabrachial nucleus (LPBN) would prevent angiotensin II-induced hypertension in rats."7.68Lateral parabrachial nucleus and angiotensin II-induced hypertension. ( Fink, GD; Haywood, JR; Ohman, LE; Pawloski, CM, 1991)
"Twenty-one patients have been treated for hypertension with oral doses of hexamethonium salts, Apresoline(R) or combinations of both."7.63Hexamethonium and hydralazine hydrochloride for treatment of hypertension. ( STUPPY, LJ, 1954)
"When hexamethonium was used to assess autonomic control of MAP, no differences in the decrease of MAP in response to ganglionic blockade were detected during the induction."5.40CNS neuroplasticity and salt-sensitive hypertension induced by prior treatment with subpressor doses of ANG II or aldosterone. ( Beltz, T; Clayton, SC; Johnson, AK; Xue, B; Zhang, Z, 2014)
"Nicotine (200 mg/kg) was administered as a single bolus, as infusions lasting 7."5.30Tachyphylaxis and sensitization to nicotine-induced tachycardiac and pressor effects after nicotine infusions. ( Cruz, SL; Vidrio, H, 1997)
"Pretreatment with prazosin (0."5.28Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area. ( Bouysset, F; Laubie, M; Schmitt, H; Vayssettes-Courchay, C; Verbeuren, TJ, 1991)
"Hexamethonium is a potent anti-hypertensive agent."5.23Use of hexamethonium in arterial hypertension. ( RYTAND, DA, 1954)
" Some of this information includes: the unexpected yet very real hazards as well as benefits associated with the long-term use of powerful drugs, in particular the original description of hydralazine-induced lupus, its relation to genetic markers and its association with control of hypertension; the apparently decreasing need for antihypertensive drugs in subjects with well-controlled severe and moderate hypertension; the identification of risk factors for the complications of hypertension and the quantitation of their effects; the decrease in the incidence of hypertensive complications associated with the pharmacologic treatment of severe, moderate and, at least, the upper ranges of mild hypertension; the possibility of designing a chemical to block a specific reaction and the realization that it would have broader than expected effects; and the primary prevention of myocardial infarction in very high risk subjects."4.77The evolution of antihypertensive therapy. ( Perry, HM, 1985)
"This study aimed to evaluate whether exercise training could contribute to a better modulation of the neurohumoral mechanisms linked to the pathophysiology of arterial hypertension (AH) in postmenopausal hypertensive rats treated with hydrochlorothiazide (HCTZ)."4.31Concurrent exercise training induces additional benefits to hydrochlorothiazide: Evidence for an improvement of autonomic control and oxidative stress in a model of hypertension and postmenopause. ( Bernardes, N; da Silva Dias, D; De Angelis, K; Ferreira, MJ; Irigoyen, MC; Santos Ferreira Silva, MPD, 2023)
"Lead is considered a causative factor for hypertension and other cardiovascular diseases."3.85Sub-chronic lead exposure produces β ( Alonso, MJ; Fioresi, M; Salaices, M; Simões, MR; Toscano, CM; Vassallo, DV, 2017)
"Early hexamethonium treatment attenuates acute excessive release of catecholamines to prevent cardiac dysfunction and pulmonary edema for increasing survival rate."3.79Hexamethonium reverses the lethal cardiopulmonary damages in a rat model of brainstem lesions mimicking fatal enterovirus 71 encephalitis. ( Ger, LP; Ho, WY; Hsiao, M; Hsieh, KS; Lai, CC; Lu, PJ; Lu, WH; Tseng, CJ; Wang, JS; Wu, YS, 2013)
"Many studies have implicated both angiotensin II (ANG II) and aldosterone (Aldo) in the pathogenesis of hypertension, the progression of renal injury, and cardiac remodeling after myocardial infarction."3.77Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension. ( Beltz, TG; Gomez-Sanchez, CE; Guo, F; Hay, M; Johnson, AK; Xue, B; Yu, Y, 2011)
"This study was conducted to examine if central amiloride-sensitive transport systems are involved in the development and/or maintenance of hypertension in spontaneously hypertensive rats (SHR)."3.71Contribution of central amiloride-sensitive transport systems to the development of hypertension in spontaneously hypertensive rats. ( Akahoshi, M; Kitamura, S; Nagao, S; Nonaka, M; Seto, S; Yano, K, 2001)
"Because the ET(B) receptor is important in venoconstriction, we examined the effects of a selective ET(B) receptor antagonist (A-1 92621) and a mixed ET(A/B) receptor antagonist (A-182086) on endogenous endothelin-1 (ET-1) contributions to elevated venomotor tone in deoxycorticosterone acetate-salt (DOCA-salt) hypertension."3.71Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension. ( Fink, GD; Galligan, JJ; Johnson, RJ, 2001)
"To explore the pathophysiological role of leptin in obesity-related hypertension, we examined cardiovascular phenotypes of transgenic skinny mice whose elevated plasma leptin concentrations are comparable to those seen in obese subjects."3.70Pathophysiological role of leptin in obesity-related hypertension. ( Aizawa-Abe, M; Ebihara, K; Hayashi, T; Hosoda, K; Inoue, G; Iwai, H; Masuzaki, H; Matsuoka, N; Nakao, K; Ogawa, Y; Satoh, N; Yoshimasa, Y, 2000)
"The purpose of the present study was to identify mechanisms that contribute to increased venous smooth muscle tone in desoxycorticosterone acetate (DOCA)-salt hypertension in rats."3.70Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension. ( Fink, GD; Galligan, JJ; Johnson, RJ, 2000)
"After saline pretreatment, response to 5-HT consisted of immediate and brief apnea, bradycardia, and hypotension, followed by sustained tachypnea, tachycardia, pulmonary hypertension, and hypocapnic hypoxemia."3.69Parasympathetic component of 5-hydroxytryptamine-induced pulmonary dysfunctions in healthy calves. ( Amory, H; Desmecht, DJ; Lekeux, PM; Linden, AS, 1996)
"We examined the effect of pioglitazone, a thiazolidinedione derivative that increases insulin sensitivity without increasing insulin secretion, on the development and maintenance of hypertension in sucrose-fed SHR."3.69Reduction of insulin resistance attenuates the development of hypertension in sucrose-fed SHR. ( Fujita, H; Hatta, T; Itoh, H; Kawa, T; Kiyama, M; Miki, S; Moriguchi, J; Morimoto, S; Nakagawa, M; Nakamura, K; Nakata, T; Sasaki, S; Takeda, K; Uchida, A, 1997)
" To investigate the mechanisms by which bupivacaine may act within the CNS to produce cardiovascular toxicity, we studied four groups of halothane-anesthetized rabbits in which infusion of intracerebroventricular (icv) bupivacaine or intravenous (iv) phenylephrine resulted in dysrhythmias and hypertension."3.68Hexamethonium and midazolam terminate dysrhythmias and hypertension caused by intracerebroventricular bupivacaine in rabbits. ( Artu, AA; Bernards, CM, 1991)
"The objective of this study was to determine if ablation of the lateral parabrachial nucleus (LPBN) would prevent angiotensin II-induced hypertension in rats."3.68Lateral parabrachial nucleus and angiotensin II-induced hypertension. ( Fink, GD; Haywood, JR; Ohman, LE; Pawloski, CM, 1991)
"To elucidate the role of the dopaminergic system in the maintenance of hypertension in the deoxycorticosterone acetate (DOCA)/NaCl hypertensive rat, the responses of mean arterial pressure (MAP), plasma norepinephrine (NE), epinephrine (E), and prolactin (PRL) to intravenous (iv) administration of bromocriptine, a dopamine agonist, and hexamethonium bromide, a ganglion blocker, were examined in conscious, unrestrained 4-wk DOCA/NaCl hypertensive rats."3.67Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat. ( Chen, YF; Nagahama, S; Oparil, S, 1985)
"A central pressor effect of angiotensin II (ANG II) has been implicated in the pathogenesis of several forms of experimental hypertension."3.67Neurohumoral contributions to chronic angiotensin-induced hypertension. ( Bruner, CA; Fink, GD, 1986)
"Twenty-one patients have been treated for hypertension with oral doses of hexamethonium salts, Apresoline(R) or combinations of both."3.63Hexamethonium and hydralazine hydrochloride for treatment of hypertension. ( STUPPY, LJ, 1954)
"When hexamethonium was used to assess autonomic control of MAP, no differences in the decrease of MAP in response to ganglionic blockade were detected during the induction."1.40CNS neuroplasticity and salt-sensitive hypertension induced by prior treatment with subpressor doses of ANG II or aldosterone. ( Beltz, T; Clayton, SC; Johnson, AK; Xue, B; Zhang, Z, 2014)
"Obesity is one of the major risk factors for cardiovascular disease and is often associated with increased oxidative stress and sympathoexcitation."1.35Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. ( Ando, K; Fujita, M; Fujita, T; Kawarazaki, H; Matsui, H; Nagae, A, 2009)
"Losartan-treated (LOS group, n = 10) and untreated rats served as controls (n = 11)."1.35Hyperinsulinemic rats are normotensive but sensitized to angiotensin II. ( Alexanderson, C; Andersson, IJ; Bergström, G; Holmäng, A; Johansson, ME; Skøtt, O, 2008)
"Hypertension was induced in male Sprague-Dawley rats (n=40) by suprarenal aortic coarctation."1.30Food restriction attenuates the blood pressure response to paraventricular hypothalamic nuclei lesions in aortic coarctation hypertension. ( Casto, RM; DeMaria, JE; Overton, JM; VanNess, JM, 1998)
"Nicotine (200 mg/kg) was administered as a single bolus, as infusions lasting 7."1.30Tachyphylaxis and sensitization to nicotine-induced tachycardiac and pressor effects after nicotine infusions. ( Cruz, SL; Vidrio, H, 1997)
" At 16 weeks of age more-complete dose-response curves to the alpha 1-agonist methoxamine were also constructed."1.29Arterial hypertrophy and pressor responsiveness during development of hypertension in spontaneously hypertensive rats. ( Lee, RM; Leenen, FH; Tsoporis, J; Yuan, B, 1994)
"Pretreatment with hexamethonium prevented neither acute nor more enduring behavioral deficits observed after TBI."1.28Blockade of acute hypertensive response does not prevent changes in behavior or in CSF acetylcholine (ACH) content following traumatic brain injury (TBI). ( Enters, EK; Kapasi, MZ; McDowell, KP; Pascua, JR; Povlishock, JT; Robinson, SE, 1992)
"Pretreatment with prazosin (0."1.28Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area. ( Bouysset, F; Laubie, M; Schmitt, H; Vayssettes-Courchay, C; Verbeuren, TJ, 1991)
"Hexamethonium is a potent anti-hypertensive agent."1.23Use of hexamethonium in arterial hypertension. ( RYTAND, DA, 1954)

Research

Studies (275)

TimeframeStudies, this research(%)All Research%
pre-1990196 (71.27)18.7374
1990's33 (12.00)18.2507
2000's32 (11.64)29.6817
2010's12 (4.36)24.3611
2020's2 (0.73)2.80

Authors

AuthorsStudies
Braga, DCA1
Gomes, PM2
Batista, MAC1
de Souza, JA1
Bastos, JCSA1
Rodrigues-das-Dôres, RG1
Alzamora, AC2
de Souza, GHB1
de Moura, SAL1
Talvani, A1
Antunes, VR2
Cardoso, LM2
Ferreira, MJ1
Santos Ferreira Silva, MPD1
da Silva Dias, D1
Bernardes, N1
Irigoyen, MC1
De Angelis, K2
Toscano, CM1
Simões, MR1
Alonso, MJ1
Salaices, M1
Vassallo, DV2
Fioresi, M1
Sá, RWM1
Aguiar, GL1
Paes, MHS1
Lima, WG1
de Oliveira, LB1
Stocker, SD1
Guild, SJ1
Saxena, UA1
McBryde, FD1
Malpas, SC1
Ramchandra, R1
Nyquist, P1
Wang, Y1
Chen, L1
Wier, WG1
Zhang, J1
Clayton, SC1
Zhang, Z1
Beltz, T1
Xue, B5
Johnson, AK5
Koga, Y1
Hirooka, Y2
Araki, S1
Nozoe, M1
Kishi, T1
Sunagawa, K1
Nagae, A1
Fujita, M1
Kawarazaki, H1
Matsui, H1
Ando, K3
Fujita, T3
Badaue-Passos, D1
Guo, F3
Gomez-Sanchez, CE2
Hay, M4
Moreira, TS1
Takakura, AC1
Colombari, E2
Menani, JV2
Moritz, KM1
Dodic, M1
Jefferies, AJ1
Wintour, EM1
DeMatteo, R1
Singh, RR1
Evans, RG1
Singh, M1
Beltz, TG2
Yu, Y1
Zhao, G1
Walsh, E1
Shryock, JC1
Messina, E1
Wu, Y1
Zeng, D1
Xu, X1
Ochoa, M1
Baker, SP1
Hintze, TH1
Belardinelli, L1
Kuroki, MT1
Guzman, PA1
Fink, GD6
Osborn, JW3
Nishida, Y1
Tandai-Hiruma, M1
Kemuriyama, T1
Hagisawa, K1
Leal, AK2
Murphy, MN1
Iwamoto, GA1
Mitchell, JH2
Smith, SA2
Lu, WH1
Hsieh, KS1
Lu, PJ1
Wu, YS1
Ho, WY1
Lai, CC1
Wang, JS1
Ger, LP1
Hsiao, M1
Tseng, CJ1
Sato, MA1
Schoorlemmer, GH1
Lopes, OU1
CAMERON, AJ1
BURN, RA1
MILLS, LC4
MOYER, JH13
SMIRK, FH7
LANE, R1
MCQUEEN, EG1
PALMER, AJ1
KVALE, WF1
MCCALLA, LH1
CREECH, O1
FORD, RV7
KELLEY, RT1
FREIS, ED5
HIGGINS, TF1
SHAW, GB2
PAGE, IH2
PAGE, I1
TAYLOR, RD1
CORCORAN, AC1
LIAN, C1
SNYDER, BH1
JOHNSON, I2
MILLER, SI5
CARRAL, R1
TRANCHESI, J1
SOTO ROJAS, G1
HERRMANN, GR1
CONWAY, J2
RICH, CB1
HOLUBITSKY, WH1
ROEHM, DC1
KORY, RC1
MENEELY, GR1
MORRISON, B3
SHAPERA, RP1
LANG, FR1
ROMNEY, RB1
BULLINGTON, RH1
ABILDSKOV, JA1
RAY, CT1
BURCH, GE1
KLAYMAN, MI1
SILBERG, NR1
KARLEN, WS1
KUHN, PH1
HIRSHLEIFER, I1
SCHWARTZ, G1
FISHMAN, SI1
FANKHAUSER, AM1
HAUGEN, HN1
BLEGEN, EM1
SHAPIRO, AP1
GROLLMAN, A1
GROB, D2
LANGFORD, HG2
HILKER, RR1
RHOADS, PS1
BILLINGS, CE1
LIVESAY, WR1
SNYDER, HB1
Rønnov-Jessen, V5
Bech, V1
SCARBOROUGH, WR1
KATTUS, AA1
BRUNNER, D3
RAFSKY, HA1
HORONICK, A1
RAFSKY, JC1
RONNOV-JESSEN, V1
DEWAR, HA2
OWEN, SG1
JENKINS, AR1
CUBBERLY, RB1
WIESEL, LL1
LAMB, AE1
MURPHY, EA2
EASTWOOD, J1
STEEVES, LC1
SHEARS, AH1
SPELLER, SL1
McCUBBIN, JW1
SIEBER, HA3
GRIMSON, KS1
ORGAIN, ES3
SPURR, CL2
DUPUY, HJ1
SIGNORELLI, JJ1
HULL, E1
GALEN, WP2
JOHNSON, LL1
WILSON, AG1
HARINGTON, M1
ROSENHEIM, ML1
FRANCO, A1
CRUMPTON, CW2
ROWE, GG2
O'BRIEN, G1
MURPHY, QR2
DONIACH, I1
STEINER, RE2
STUPPY, LJ1
PERRETTA, A2
GUIDO, JJ1
WILSON, VH1
KEELEY, KJ1
HOOD, B1
BJORK, S1
ANGERVALL, G1
RUDBACK, H1
RYTAND, DA1
GREEN, DM1
ELLIS, EJ1
EURMAN, GH1
MENDLOWITZ, M1
CAPRETTI, G1
MAGNANI, B2
FALZOI, M1
GELATI, M1
GUNELLA, G1
SCHIMMLER, W1
SCHWALB, H1
CESARMAN, T1
TORRES DEL TORO, JM1
BARNETT, AJ1
FRASER, JR1
HAMILTON, M1
HENLEY, KS1
MANDELBAUM, H1
BROOK, J1
MANDELBAUM, RA1
ROSSI, B1
FERRARA, FA1
LEMAIRE, A1
LOEPER, J1
HOUSSET, E1
FRANCO, R1
ESCALADA, JG1
ALONSO JIMENO, S1
GONZALEZ MARTINEZ, A1
CRAWLEY, CJ2
SILVIS, GM2
STUMPE, WM2
WHITE, L1
THOMSEN, P1
ORTUZAR, R1
GONI, F1
ROJAS VILLEGAS, F1
SILVA LAFRENTZ, C1
TOLEDO, P1
SILVA CLARK, A1
VERA, G1
CHIAVERINI, R1
DA SILVA, WN1
DUKE, JE1
KLEH, J1
FAZEKAS, JF1
GUIDO, JG1
NAVARRET, E1
DENNIS, E3
McCONN, RG1
HUGHES, WM2
BEAZLEY, HL1
BIRKHEAD, NC1
ALLEN, EV1
RAST, CL2
SMITH, KS1
FOWLER, PB1
EDMUNDS, V1
HRENOFF, AK1
LOVISATO, L1
ROQUE, JA1
GENEST, J3
ROBILLARD, R3
TREMBLAY, G3
ADAMKIEWICZ, L3
CAPPS, RC1
WHITMORE, JJ1
BURCH, RR1
DE SIMONE, G1
MASELLIS, F1
GOLDSMITH, HJ1
BEAVEN, DW1
LAMBERT, HP1
TARJAN, P1
CSIPAK, Z1
BARATH, J1
BRUCE, GM1
MULLER, JC1
PRYOR, WW1
PIPBERGER, H1
KALIN, R1
ROSSIER, PH1
MCCLOSKEY, BJ1
FORD, R1
HERSCHBERGER, R1
SPENCE, W1
HERSHBERGER, RL1
BONA, E1
LOVEI, E1
PERALTA, A1
CASTANEDA, L1
ARREDONDO, J1
PEREZ, V1
CAMACHO, J1
ESTELA, M1
AUINGER, W1
HEROLD, G1
SALAND, G1
FISCHER, I1
HERNRIED, HP1
STOLIAR, ED1
ZURROW, HB1
ULLMANN, TD1
MENCZEL, J1
BARTORELLI, C1
GOLDBERG, B2
DALLE COSTE, P1
KLINGER, R1
ETTMAN, IK1
BOUCHILLON, CD1
HALFORD, HH1
BALCHUM, OJ1
GENSINI, G1
BLOUNT, SG1
LINDAUER, MA1
HAFKENSCHIEL, JH1
RESTREPO, G1
BAUER, H1
ERLSBACHER, O1
GEISBERGER, H1
MEDA, A1
DUGHERA, L1
PETERSEN, AG1
DODGE, M1
HELWIG, FC1
HAYNES, FW1
DEXTER, L1
VARELA DE SEIJAS AGUILAR, J1
FERNANDEZ ARENAS, M1
ESQUIVEL JIMENEZ, A1
MARCHAN COLADO, A1
DIAZ, JM1
KALUGINA, GV1
MOSCHINI-ANTINORI, E1
MENOTTI, A1
SPLENDIANI, G1
BARDIN, EV1
AKHREM-AKHREMOVICH, RM1
CHISTIAKOVA, MA1
KONONIACHENKO, VA1
CHAPIDZE, GE1
HAZARD, R1
RENIER CORNEC, A1
IVANOV, IuM1
BANTOVA, TG1
SANCETTA, SM1
RIOPELLE, JL1
MARKOVITZ, M1
KOIK, JV1
HICK, FK1
GRISSOM, RL1
GRIGOLATO, V1
ALLAN, J1
STEIN, DH1
HECHT, HH1
FERRARI, S1
MOSER, M1
ALTMAN, S1
SCHINDEL, L1
HIMBERT, J1
GRAS, H1
PHELAN, EL1
ERYETISHIR, I1
Toscano, CF1
Lahlou, S1
CAMPBELL, A1
ROBERTSON, E1
McNALLY, PA1
CUSACK, PB1
CUSACK, AL1
ALSTAD, KS1
MACKEY, WA1
COUNIHAN, T1
WERKO, L1
WADE, G1
FRISK, AR1
ELLASCH, H1
BECHGAARD, P1
IVERSEN, T1
NIELSEN, AL1
LOCKET, S1
SWANN, PG1
GRIEVE, WS1
PLAYER, HP1
FINNERTY, FA1
SCHNAPER, NW1
JOHNSON, RL2
PERSSON, I1
SCHROEDER, HA1
CHAPMAN, OW1
SCHNAPER, HW1
FREEMAN, Z1
KOK, JF1
DI CIO, AV1
KLEIN, L1
LOPEZ, A1
PAZZANESE, D1
DE BARROS, LM1
DE CAMARGO, FS1
BURT, CC1
GRAHAM, AJ1
RESTALL, PA1
Hendel, MD1
Collister, JP2
Pamidimukkala, J1
Seto, S2
Nagao, S2
Ozeki, S1
Tetsuo, H1
Akahoshi, M2
Yano, K2
O'Donaughy, TL1
Qi, Y1
Brooks, VL1
Williams, MA1
Garry, MG1
Zoccal, DB1
Bonagamba, LG1
Oliveira, FR1
Antunes-Rodrigues, J1
Machado, BH1
Freitas, RR1
Lopes, KL1
Carillo, BA1
Bergamaschi, CT1
Carmona, AK1
Casarini, DE1
Furukawa, L1
Heimann, JC1
Campos, RR1
Dolnikoff, MS1
Maeda, C1
Schaan, B1
Oliveira, E1
Oliveira, V1
Irigoyen, M1
Chen, X1
Patel, K1
Connors, SG1
Mendonca, M1
Welch, WJ2
Wilcox, CS2
Guzman, P1
Johansson, ME1
Andersson, IJ1
Alexanderson, C1
Skøtt, O1
Holmäng, A1
Bergström, G1
Lizardo, JH1
Silveira, EA1
Oliveira, EM1
Maixner, W1
Touw, KB1
Brody, MJ1
Gebhart, GF1
Long, JP1
Brennan, TJ1
Haywood, JR2
Ticku, MK1
Panikarskiĭ, VG1
Barnes, KL1
Averill, DB1
Ferrario, CM1
Sorrentino, R1
Pinto, A1
Santajuliana, D1
Zukowska-Grojec, Z1
Toda, N1
Kitamura, Y1
Okamura, T1
Nakagawa, M3
Takeda, K3
Yoshitomi, T1
Itoh, H2
Nakata, T3
Sasaki, S3
Leenen, FH5
Yuan, B2
Tsoporis, J1
Lee, RM1
Ono, A1
Sato, Y2
Asano, S1
Amano, M1
Asari, T1
Kubo, T1
Yang, TL1
Yen, CT2
Chai, CY2
Wyss, JM3
Mozaffari, MS2
Roysommuti, S2
Linden, AS1
Desmecht, DJ1
Amory, H1
Lekeux, PM1
Momohara, M1
Imaizumi, T1
Endo, T1
Suzuki, S1
Tagawa, T1
Shiramoto, M1
Masaki, H1
Takeshita, A2
Cruz, SL1
Vidrio, H1
Oosting, J1
Struijker-Boudier, HA1
Janssen, BJ2
Uchida, A1
Hatta, T1
Kiyama, M1
Kawa, T1
Morimoto, S1
Miki, S1
Moriguchi, J1
Nakamura, K1
Fujita, H1
Gao, H1
DiBona, GF1
VanNess, JM1
Casto, RM1
DeMaria, JE1
Overton, JM1
Radaelli, A1
Mircoli, L1
Mori, I1
Mancia, G1
Ferrari, AU1
Han, CJ1
Tsai, ML1
Chen, RF1
Davisson, RL1
Yang, G1
Cassell, MD1
Sigmund, CD1
Chen, Y1
Collins, HL1
DiCarlo, SE1
Nagayama, T1
Matsumoto, T1
Yoshida, M1
Suzuki-Kusaba, M1
Hisa, H1
Kimura, T1
Satoh, S1
Amos, S1
Akah, PA1
Odukwe, CJ1
Gamaniel, KS1
Wambede, C1
Carlson, SH1
Shelton, J1
White, CR1
Johnson, RJ2
Galligan, JJ2
Greyson, C1
Xu, Y1
Lu, L1
Schwartz, GG1
Aizawa-Abe, M1
Ogawa, Y1
Masuzaki, H1
Ebihara, K1
Satoh, N1
Iwai, H1
Matsuoka, N1
Hayashi, T1
Hosoda, K1
Inoue, G1
Yoshimasa, Y1
Nakao, K1
Eshima, K1
Shigematsu, H1
Matsuo, I1
Koike, G1
Sakai, K1
Iriuchijima, J2
Rong, P1
Wilkinson-Berka, JL1
Skinner, SL1
Kitamura, S1
Nonaka, M1
Teranishi, Y1
Sugino, H1
Ozono, R1
Ishioka, N1
Kumazaki, T1
Tsuru, H1
Ueno, K1
Togashi, H1
Matsumoto, M1
Ohashi, S1
Saito, H1
Yoshioka, M1
Boura, AL1
Abdel-Rahman, AA1
Carroll, RG1
el-Mas, MM1
Enters, EK1
Pascua, JR1
McDowell, KP1
Kapasi, MZ1
Povlishock, JT1
Robinson, SE1
Bernards, CM1
Artu, AA1
Pawloski, CM2
Ohman, LE1
Vayssettes-Courchay, C1
Bouysset, F1
Verbeuren, TJ1
Laubie, M1
Schmitt, H1
Stoos, BA1
Metting, PJ1
Britton, SL1
Takata, Y2
Yamashita, Y2
Takishita, S2
Tomita, Y1
Tsuchihashi, T1
Nakao, Y1
Iwase, M1
Sadoshima, S1
Fujishima, M2
van Essen, H1
Vervoort-Peters, LH1
Struyker-Boudier, HA1
Smits, JF1
Itho, H1
Hirata, M1
Kawasaki, S1
Hayashi, J1
Oguro, M1
Otsuka, A1
Ogihara, T1
Mikami, H1
Kohara, K1
Katahira, K1
Tsunetoshi, T1
Kumahara, Y1
Arranz, CT1
Balaszczuk, AM1
Martínez-Seeber, A1
Gradin, K1
Elam, M1
Persson, B1
Nagahama, S1
Chen, YF1
Oparil, S1
Perry, HM1
Bruner, CA1
Neiko, EM1
Berezhnitskiĭ, MN1
Shvedenko, LA1
Kupnovitskaia, IG1
Mikhal'chuk, BD1
Sjövall, H1
Ely, D1
Westlander, G1
Köhlin, T1
Jodal, M1
Lundgren, O1
Zambraski, EJ1
Ciccone, CD1
Izzo, JL1
Kimura, Y1
Marzán, G1
Enero, MA1
Toal, CB1
Blair, ML1
Mangiapane, ML1
Wilczynski, EA2
Tucker, DC1
Domino, JV1
Kaskel, FJ1
Devarajan, P1
Persan, L1
Juno, CJ1
Wilson, TA1
McCaughran, JA1

Reviews

2 reviews available for hexamethonium and Blood Pressure, High

ArticleYear
Long-term blood pressure control: is there a set-point in the brain?
    The journal of physiological sciences : JPS, 2012, Volume: 62, Issue:3

    Topics: Animals; Arginine Vasopressin; Baroreflex; Blood Pressure; Brain; Heart Rate; Hexamethonium; Homeost

2012
The evolution of antihypertensive therapy.
    The American journal of cardiology, 1985, Dec-06, Volume: 56, Issue:16

    Topics: Antihypertensive Agents; Bis-Trimethylammonium Compounds; Blood Pressure; Calcium Channel Blockers;

1985

Other Studies

273 other studies available for hexamethonium and Blood Pressure, High

ArticleYear
Effects of Psidium guajava L. leaves extract on blood pressure control and IL-10 production in salt-dependent hypertensive rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 155

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Chromatography, Liquid; Hexamethonium; Hypertensio

2022
Concurrent exercise training induces additional benefits to hydrochlorothiazide: Evidence for an improvement of autonomic control and oxidative stress in a model of hypertension and postmenopause.
    PloS one, 2023, Volume: 18, Issue:8

    Topics: Animals; Baroreflex; Blood Pressure; Female; Heart Rate; Hexamethonium; Hydrochlorothiazide; Hyperte

2023
Sub-chronic lead exposure produces β
    Life sciences, 2017, Jul-01, Volume: 180

    Topics: Animals; Arterial Pressure; Cardiovascular Diseases; Down-Regulation; Heart Rate; Hexamethonium; Hyp

2017
Chronic high-sodium diet intake after weaning lead to neurogenic hypertension in adult Wistar rats.
    Scientific reports, 2017, 07-18, Volume: 7, Issue:1

    Topics: Animals; Antihypertensive Agents; Blood Pressure Determination; Heart Rate; Hexamethonium; Hypertens

2017
Intracranial pressure influences the level of sympathetic tone.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2018, 11-01, Volume: 315, Issue:5

    Topics: Animals; Baroreflex; Blood Pressure; Brain; Cerebrovascular Circulation; Hexamethonium; Hypertension

2018
Wet lungs and a battered brain stem: can we stop one if we cannot stop the other?
    Critical care medicine, 2013, Volume: 41, Issue:5

    Topics: Animals; Encephalitis, Viral; Enterovirus Infections; Hexamethonium; Hypertension; Male; Pulmonary E

2013
Intravital Förster resonance energy transfer imaging reveals elevated [Ca2+]i and enhanced sympathetic tone in femoral arteries of angiotensin II-infused hypertensive biosensor mice.
    The Journal of physiology, 2013, Nov-01, Volume: 591, Issue:21

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Biosensing Techniques; Calcium; Calcium Signaling;

2013
CNS neuroplasticity and salt-sensitive hypertension induced by prior treatment with subpressor doses of ANG II or aldosterone.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2014, Jun-15, Volume: 306, Issue:12

    Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Brain; Brain-Derived

2014
High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:11

    Topics: Animals; Blood Pressure; Cyclic N-Oxides; Heart Rate; Hexamethonium; Hypertension; Male; Medulla Obl

2008
Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension.
    Circulation, 2009, Feb-24, Volume: 119, Issue:7

    Topics: Acetophenones; Animals; Blood Pressure; Brain; Cyclic N-Oxides; Heart Rate; Hexamethonium; Hypertens

2009
Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone/NaCl-induced hypertension.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:5

    Topics: Administration, Oral; Aldosterone; Animals; Blood Pressure; Body Weight; Brain; Disease Models, Anim

2009
Antihypertensive effects of central ablations in spontaneously hypertensive rats.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2009, Volume: 296, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Baroreflex; Blood Pressur

2009
Haemodynamic characteristics of hypertension induced by prenatal cortisol exposure in sheep.
    Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:10

    Topics: Animals; Antihypertensive Agents; Female; Hemodynamics; Hexamethonium; Hydrocortisone; Hypertension;

2009
Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:5

    Topics: Angiotensin II; Animals; Blood Pressure; Blotting, Western; Disease Models, Animal; Enzyme Inhibitor

2009
Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 300, Issue:2

    Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Blotting, Western; Drug Interactions; Electrop

2011
Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs.
    Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:6

    Topics: Acetanilides; Adrenergic Antagonists; Animals; Autonomic Agents; Coronary Circulation; Dogs; Dose-Re

2011
Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension.
    American journal of physiology. Heart and circulatory physiology, 2012, Feb-01, Volume: 302, Issue:3

    Topics: Angiotensin II; Animals; Blood Pressure; Ganglionic Blockers; Heart Rate; Hexamethonium; Hypertensio

2012
A role for nitric oxide within the nucleus tractus solitarii in the development of muscle mechanoreflex dysfunction in hypertension.
    Experimental physiology, 2012, Volume: 97, Issue:12

    Topics: Animals; Blood Pressure; Disease Models, Animal; Enzyme Inhibitors; Ganglionic Blockers; Heart Rate;

2012
Hexamethonium reverses the lethal cardiopulmonary damages in a rat model of brainstem lesions mimicking fatal enterovirus 71 encephalitis.
    Critical care medicine, 2013, Volume: 41, Issue:5

    Topics: Animals; Biopsy, Needle; Brain Stem; Catecholamines; Diagnosis, Differential; Disease Models, Animal

2013
Recovery of high blood pressure after chronic lesions of the commissural NTS in SHR.
    Hypertension (Dallas, Tex. : 1979), 2003, Volume: 42, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Argini

2003
Hexamethonium and glaucoma.
    The British journal of ophthalmology, 1952, Volume: 36, Issue:9

    Topics: Glaucoma; Hexamethonium; Hypertension; Muscle Relaxants, Central

1952
Treatment of hypertension with orally and parenterally administered purified extracts of veratrum viride; comparison with ganglionic (Hexamethonium) and adrenergic blocking agents.
    A.M.A. archives of internal medicine, 1952, Volume: 90, Issue:5

    Topics: Adrenergic Antagonists; Ganglia; Hexamethonium; Hypertension; Veratrum; Veratrum Alkaloids

1952
Hypotensive actions of hexamethonium bromide and some of its homologues; their use in high blood-pressure.
    Lancet (London, England), 1952, Nov-22, Volume: 2, Issue:6743

    Topics: Autonomic Agents; Hexamethonium; Hypertension

1952
The uses of hexamethonium.
    Journal of the Indian Medical Association, 1952, Volume: 21, Issue:12

    Topics: Anesthesia; Cardiovascular Agents; Gastrointestinal Diseases; Hexamethonium; Humans; Hypertension; M

1952
Treatment of hypertension with hexamethonium bromide.
    The Medical journal of Australia, 1952, Sep-27, Volume: 2, Issue:13

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1952
The management of hypertension with hexamethonium bromide.
    The Medical journal of Australia, 1952, Sep-27, Volume: 2, Issue:13

    Topics: Cardiovascular Agents; Disease Management; Hexamethonium; Hypertension; Muscle Relaxants, Central

1952
Hexamethonium and apresoline (1-hydrazinophthalazine).
    Proceedings of the staff meetings. Mayo Clinic, 1952, Nov-19, Volume: 27, Issue:24

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho

1952
Hexamethonium ileus.
    The American surgeon, 1953, Volume: 19, Issue:2

    Topics: Hexamethonium; Hypertension; Ileus; Intestinal Obstruction; Muscle Relaxants, Central

1953
The effects of hexamethonium on certain manifestations of congestive heart failure.
    Circulation, 1953, Volume: 7, Issue:2

    Topics: Cardiovascular Agents; Heart Failure; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
Continous oral hexamethonium in essential hypertension; further experiences in treatment.
    Glasgow medical journal, 1952, Volume: 33, Issue:10

    Topics: Cardiovascular Agents; Essential Hypertension; Hexamethonium; Hypertension; Muscle Relaxants, Centra

1952
The treatment of severe arterial hypertension with hexamethonium and hydrazinophthalazine.
    Journal of the Medical Association of Georgia, 1953, Volume: 42, Issue:2

    Topics: Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics

1953
[The treatment of severe arterial hypertension with hexamethonium and hydrazinophthalazine].
    Die Medizinische, 1952, Nov-29, Volume: 20, Issue:48

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho

1952
[Current medical and surgical therapy of permanent arterial hypertension; salt-free diet; tetraethylammonium; hexamethonium; extensive sympathectomies; arteriovenous fistula].
    La Semana medica, 1952, Aug-07, Volume: 101, Issue:6

    Topics: Arteriovenous Fistula; Diet, Sodium-Restricted; Fistula; Hexamethonium; Humans; Hypertension; Sympat

1952
Results with oral hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the therapy of hypertension.
    The American journal of the medical sciences, 1953, Volume: 225, Issue:4

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho

1953
[Treatment of arterial hypertension with hexamethonium].
    Archivos del Instituto de Cardiologia de Mexico, 1952, Volume: 22, Issue:5

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1952
Some reactions to apresoline, hexamethonium and hydergine.
    Archivos del Instituto de Cardiologia de Mexico, 1952, Volume: 22, Issue:5

    Topics: Cardiovascular Agents; Ergoloid Mesylates; Ergot Alkaloids; Hexamethonium; Hydralazine; Hypertension

1952
Sensitivity of autonomic ganglia to hexamethonium in hypertension.
    British medical journal, 1953, Apr-11, Volume: 1, Issue:4814

    Topics: Autonomic Agents; Ganglia, Autonomic; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
The treatment of hypertension with oral hexamethonium.
    Canadian Medical Association journal, 1953, Volume: 68, Issue:4

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
Responses of the ballistocardiogram in hypertensive patients to the acute administration of apresoline, hexamethonium, veratrone, regitine and sodium amytal.
    Circulation, 1953, Volume: 7, Issue:3

    Topics: Amobarbital; Ballistocardiography; Barbiturates; Cardiovascular Agents; Hexamethonium; Hydralazine;

1953
Dibenzyline: results of therapy in patients with hypertension and a comparison with hexamethonium, 1-hydrazinophthalazine and semipurified extracts of veratrum.
    The New England journal of medicine, 1953, Apr-02, Volume: 248, Issue:14

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Phenoxyb

1953
Parenteral hexamethonium in hypertension.
    British medical journal, 1953, Jun-13, Volume: 1, Issue:4823

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
Essential hypertension; treatment with hexamethonium and apresoline.
    United States Armed Forces medical journal, 1953, Volume: 4, Issue:6

    Topics: Cardiovascular Agents; Essential Hypertension; Hexamethonium; Hydralazine; Hypertension; Muscle Rela

1953
Orally administered hexamethonium chloride in hypertension.
    Journal of the American Medical Association, 1953, Jul-18, Volume: 152, Issue:12

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
A preliminary report on clinical experiences with hexamethonium and 1-hydrazinophthalazine in the treatment of diastolic hypertension.
    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1953, Volume: 105, Issue:4

    Topics: Cardiovascular Agents; Hexamethonium; Humans; Hydralazine; Hypertension; Muscle Relaxants, Central;

1953
Death associated with hexamethonium and 1-hydrazinophthalazine (apresoline) therapy.
    The New England journal of medicine, 1953, Jun-25, Volume: 248, Issue:26

    Topics: Cardiovascular Agents; Death; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; S

1953
The use of oral hexamethonium chloride (methium) in the treatment of hypertension.
    Angiology, 1953, Volume: 4, Issue:3

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
Clinical experiences with hexamethonium chloride in hypertension.
    New York state journal of medicine, 1953, May-15, Volume: 53, Issue:10

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
The renal response to hexamethonium.
    Scandinavian journal of clinical and laboratory investigation, 1953, Volume: 5, Issue:1

    Topics: Hexamethonium; Hypertension; Kidney; Muscle Relaxants, Central

1953
The acute effects of hexamethonium on renal hemodynamics in normotensive and hypertensive human subjects.
    The American journal of the medical sciences, 1953, Volume: 226, Issue:1

    Topics: Blood Pressure; Hemodynamics; Hexamethonium; Humans; Hypertension; Kidney; Muscle Relaxants, Central

1953
A critical evaluation of the hypotensive asction of hydrallazine, hexamethonium, tetraethylammonium and dibenzyline salts in human and experimental hypertension.
    Circulation, 1953, Volume: 8, Issue:2

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypotension; Muscle Relaxants, Cent

1953
Further observations on the effects of autonomic blocking agents in patients with hypertension. I. General systemic effects of hexamethonium, pentamethonium, and hydrazinophthalazine.
    Circulation, 1953, Volume: 8, Issue:2

    Topics: Bis-Trimethylammonium Compounds; Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Mu

1953
Clinical use of hydralazine and hexamethonium in treatment of hypertension.
    Journal of the American Medical Association, 1953, Sep-05, Volume: 153, Issue:1

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho

1953
Treatment of hypertension with hexamethonium alone and in combination with apresoline.
    Texas state journal of medicine, 1953, Volume: 49, Issue:7

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho

1953
[Drug therapy of arterial hypertension; preliminary report on own experience with hexamethonium].
    Ugeskrift for laeger, 1953, 04-16, Volume: 115, Issue:16

    Topics: Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
Further observations on the effects of autonomic blocking agents in patients with hypertension. II. Hemodynamic, ballistocardiographic and electrocardiographic effects of hexamethonium and pentamethonium.
    Circulation, 1953, Volume: 8, Issue:3

    Topics: Bis-Trimethylammonium Compounds; Heart; Hemodynamics; Hexamethonium; Humans; Hypertension; Kidney; M

1953
[The treatment of hypertension with hexamethonium and veriloid].
    Harefuah, 1953, Jul-15, Volume: 45, Issue:2

    Topics: Hexamethonium; Hypertension; Muscle Relaxants, Central; Veratrum Alkaloids

1953
The treatment of hypertension; experience of treatment with hexamethonium and veratrum viride preparation in 50 patients.
    Harefuah, 1953, Aug-02, Volume: 45, Issue:3

    Topics: Hexamethonium; Hypertension; Muscle Relaxants, Central; Veratrum; Veratrum Alkaloids

1953
Treatment of hypertension in elderly patients with methium chloride; preliminary report.
    Journal of the American Geriatrics Society, 1953, Volume: 1, Issue:8

    Topics: Aged; Cardiovascular Agents; Disease; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central

1953
[Preliminary results in drug therapy of hypertension, with special reference to hexamethonium bromide].
    Nordisk medicin, 1953, Jul-02, Volume: 50, Issue:27

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
Effect of hexamethonium bromide on the cerebral circulation in hypertension.
    British medical journal, 1953, Nov-07, Volume: 2, Issue:4844

    Topics: Brain; Cerebrovascular Circulation; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
The treatment of hypertension with hexamethonium and hydrazinophthalazine (apresoline).
    The Brooklyn Hospital journal, 1953, Volume: 11, Issue:3 3rd Quar

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho

1953
Exercise tests during treatment of hypertension with hexamethonium.
    Lancet (London, England), 1953, Oct-03, Volume: 265, Issue:6788

    Topics: Cardiovascular Agents; Exercise Test; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
Hexamethonium in polyvinylpyrrolidone.
    Lancet (London, England), 1953, Oct-17, Volume: 265, Issue:6790

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Povidone

1953
Newer drugs in hypertension; combined effects of 1-hydrazinophthalazine (apresoline) and hexamethonium salts; a preliminary report.
    Treatment services bulletin. Canada. Department of Veterans' Affairs, 1953, Volume: 8, Issue:9

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Salts; S

1953
Preliminary observations of Rauwiloid-hexamethonium combined therapy of hypertension.
    American heart journal, 1953, Volume: 46, Issue:5

    Topics: Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central; Rauwolfia; Se

1953
Modification of the hypotensive action of 1-hydrazinophthalazine (apresoline) by priscoline, hexamethonium and section of the carotid sinus and aortic buffer nerves in normal and renal hypertensive dogs.
    The American journal of the medical sciences, 1953, Volume: 226, Issue:6

    Topics: Animals; Aorta; Carotid Sinus; Dogs; Hexamethonium; Hydralazine; Hypertension; Kidney; Muscle Relaxa

1953
Newer drugs in the treatment of hypertension. I. Use of hexamethonium salts.
    Circulation, 1953, Volume: 8, Issue:6

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts

1953
Hexamethonium in the chronic treatment of hypertension; its effect on renal hemodynamics and on the excretion of water and electrolytes.
    The Journal of clinical investigation, 1953, Volume: 32, Issue:11

    Topics: Electrolytes; Hemodynamics; Hexamethonium; Hypertension; Kidney; Muscle Relaxants, Central; Water

1953
Hexamethonium and apresoline; their effects on ambulatory hypertensive patients.
    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1953, Volume: 105, Issue:11

    Topics: Cardiovascular Agents; Hexamethonium; Humans; Hydralazine; Hypertension; Muscle Relaxants, Central;

1953
Outpatient treatment of hypertension with hexamethonium and apresoline.
    Journal of the Medical Association of the State of Alabama, 1953, Volume: 23, Issue:3

    Topics: Ambulatory Care; Cardiovascular Agents; Hexamethonium; Humans; Hydralazine; Hypertension; Muscle Rel

1953
Effect of hexamethonium on normotensive heart failure; a possible correlation between the mechanism of essential hypertension and normotensive heart failure.
    Journal - Michigan State Medical Society, 1953, Volume: 52, Issue:12

    Topics: Essential Hypertension; Heart Failure; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
Hexamethonium in the treatment of hypertension.
    Lancet (London, England), 1954, Jan-02, Volume: 266, Issue:6801

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1954
[Results of treatment of arterial hypertension with hexamethonium and apresoline].
    Medicina contemporanea (Lisbon, Portugal), 1953, Volume: 71, Issue:8

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho

1953
[Hexamethonium in the treatment of hypertension].
    Bruxelles medical, 1953, Dec-13, Volume: 33, Issue:50

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
The effect of hexamethonium bromide upon coronary flow, cardiac work and cardiac efficiency in normotensive and renal hypertensive dogs.
    Circulation research, 1954, Volume: 2, Issue:1

    Topics: Animals; Blood Pressure; Dogs; Heart; Hexamethonium; Hypertension; Muscle Relaxants, Central

1954
Practical details of the treatment of hypertension by hexamethonium salts and by pentamethylene 1:5-bis-N-(N-methylpyrrolidinium) bitartrate (M. & B. 2050A).
    The New Zealand medical journal, 1953, Volume: 52, Issue:291

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts

1953
[Vegolysen retard, a new hexamethonium preparation with prolonged effect].
    Ugeskrift for laeger, 1953, Sep-24, Volume: 115, Issue:39

    Topics: Aged; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central; Povidone

1953
Lung changes during hexamethonium therapy for hypertension.
    British heart journal, 1954, Volume: 16, Issue:1

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Lung; Muscle Relaxants, Central

1954
Hexamethonium and hydralazine hydrochloride for treatment of hypertension.
    California medicine, 1954, Volume: 80, Issue:3

    Topics: Cardiovascular Agents; Constipation; Hexamethonium; Hydralazine; Hypertension; Hypotension, Orthosta

1954
[Behavior of hexamethonium in arterial hypertension of distinct etiopathogenesis: hexamethonium test and personal technic].
    El Dia medico, 1953, Dec-31, Volume: 25, Issue:92

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
The haemodynamic effects of hexamethonium bromide in patients with pulmonary hypertension and heart failure.
    The South African journal of medical sciences, 1953, Volume: 18, Issue:3-4

    Topics: Blood Circulation; Heart Failure; Hemodynamics; Hexamethonium; Hypertension; Hypertension, Pulmonary

1953
Muscular exercise in essential hypertension; the effect of hexamethonium chloride (C6).
    Acta medica Scandinavica, 1953, Volume: 147, Issue:3

    Topics: Essential Hypertension; Exercise; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central; Mu

1953
The treatment of the ambulatory hypertensive patient with hexamethonium administered orally.
    American practitioner and digest of treatment, 1954, Volume: 5, Issue:4

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1954
Use of hexamethonium in arterial hypertension.
    California medicine, 1954, Volume: 80, Issue:5

    Topics: Antihypertensive Agents; Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Centr

1954
Intravenous hexamethonium sensitivity and responses to oral treatment.
    Circulation, 1954, Volume: 9, Issue:4

    Topics: Administration, Oral; Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1954
The effect of prolonged sodium depletion and of hydralazine hydrochloride and hexamethonium bromide on the digital vascular resistance in primary hypertension.
    Circulation, 1954, Volume: 9, Issue:4

    Topics: Essential Hypertension; Fingers; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central

1954
[Use of hexamethonium salts in hypertensive disease].
    Giornale di clinica medica, 1954, Volume: 35, Issue:1

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts

1954
[Essential hypertension. II. Acute changes of renal function caused by hexamethonium bitartrate].
    Giornale di clinica medica, 1954, Volume: 35, Issue:1

    Topics: Essential Hypertension; Hexamethonium; Hypertension; Kidney; Muscle Relaxants, Central

1954
[Relations between arterial circulation and renal function following administration of hexamethonium bromide].
    Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1954, Volume: 221, Issue:2

    Topics: Arteries; Blood Circulation; Hexamethonium; Hypertension; Kidney; Muscle Relaxants, Central; Pharmac

1954
[Essay of the treatment of essential arterial hypertension with oral hexamethonium chloride].
    Archivos del Instituto de Cardiologia de Mexico, 1953, Dec-31, Volume: 23, Issue:6

    Topics: Essential Hypertension; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
The mechanism of arterial hypertension: a comparison of the effects of hexamethonium bromide in hypertensive and normotensive persons.
    Australasian annals of medicine, 1954, Volume: 3, Issue:2

    Topics: Blood Pressure; Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Centra

1954
Changes in peripheral circulation and body temperature after hexamethonium bromide.
    Clinical science, 1954, Volume: 13, Issue:2

    Topics: Blood Circulation; Body Temperature; Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Rela

1954
Bleeding peptic ulcer complicating hydralazine and hexamethonium bromide therapy.
    Journal of the American Medical Association, 1954, Jun-26, Volume: 155, Issue:9

    Topics: Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Peptic Ulcer; Peptic Ulcer Hemo

1954
[Action of oral hexamethonium chloride in the treatment of arterial hypertension].
    Minerva medica, 1954, Mar-03, Volume: 45, Issue:18

    Topics: Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central

1954
[Hexamethonium in the treatment of arterial hypertension].
    La Semana medica, 1954, Mar-11, Volume: 104, Issue:10

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1954
[Effect of hexamethonium on photoplethysmographic tracings in hypertension].
    Therapie, 1953, Volume: 8, Issue:6

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1953
[Hexamethonium in therapy of acute hypertensive crises, as illustrated by case reports].
    Ugeskrift for laeger, 1954, Apr-15, Volume: 116, Issue:15

    Topics: Hexamethonium; Hypertension; Muscle Relaxants, Central

1954
[Practice and results of the use of hexamethonium in the treatment of arterial hypertension].
    Revista clinica espanola, 1954, Jan-31, Volume: 52, Issue:2

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1954
Appraisal of methium chloride with Rauwolfia in ambulatory hypertensive patients.
    New York state journal of medicine, 1954, Aug-01, Volume: 54, Issue:15

    Topics: Hexamethonium; Hypertension; Hypnotics and Sedatives; Muscle Relaxants, Central; Rauwolfia

1954
[Hexamethonium, apresoline and pyretotherapy in the treatment of arterial hypertension].
    Revista medica de Chile, 1954, Volume: 82, Issue:3

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hyperthermia, Induced; Muscle Relax

1954
[Observations on the treatment of arterial hypertension with hexamethonium with hydergine].
    Revista medica de Chile, 1954, Volume: 82, Issue:3

    Topics: Cardiovascular Agents; Ergoloid Mesylates; Ergot Alkaloids; Hexamethonium; Hypertension; Muscle Rela

1954
[Hexamethonium in therapy of arterial hypertension].
    Revista paulista de medicina, 1954, Volume: 44, Issue:4

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1954
Outpatient treatment of hypertension with hexamethonium and hydralazine; a preliminary report.
    Southern medical journal, 1954, Volume: 47, Issue:9

    Topics: Ambulatory Care; Hexamethonium; Humans; Hydralazine; Hypertension; Muscle Relaxants, Central; Outpat

1954
Hexamethonium treatment of arterial hypertension.
    Danish medical bulletin, 1954, Volume: 1, Issue:4

    Topics: Hexamethonium; Humans; Hypertension; Osteomyelitis

1954
Cerebral hemodynamic studies on hypertensive-atherosclerotic subjects during hexamethonium therapy.
    The Medical annals of the District of Columbia, 1954, Volume: 23, Issue:9

    Topics: Arteriosclerosis; Brain; Cardiovascular System; Hemodynamics; Hexamethonium; Hypertension; Muscle Re

1954
[Hexamethonium bromide test in hypertensive endocrine diseases].
    El Dia medico, 1954, Jul-19, Volume: 26, Issue:49

    Topics: Cardiovascular Agents; Endocrine System Diseases; Hexamethonium; Hypertension; Muscle Relaxants, Cen

1954
Treatment of hypertension; long-term results with alseroxylon (rauwiloid) alone and combined with hexamethonium administered orally.
    Postgraduate medicine, 1954, Volume: 16, Issue:4

    Topics: Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Hypnotics and Sedatives; Muscle Relaxant

1954
Comparison of effects on hypertension of hexamethonium and pentapyrrolidinium injected subcutaneously.
    Proceedings of the staff meetings. Mayo Clinic, 1954, Sep-01, Volume: 29, Issue:18

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1954
A comparison of the effects of hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the treatment of hypertension.
    Transactions of the American Clinical and Climatological Association, 1953, Volume: 65

    Topics: Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatholytics

1953
Blood pressure reduction in arterial hypertension by hexamethonium and pentapyrrolidinium salts.
    The American journal of medicine, 1954, Volume: 17, Issue:6

    Topics: Blood Pressure; Cardiovascular Agents; Hexamethonium; Hypertension; Hypotension; Muscle Relaxants, C

1954
Hypertension and its control by hexamethonium.
    British medical journal, 1954, Nov-27, Volume: 2, Issue:4899

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1954
Hexamethonium contributing to fatal shock in hypertensive epistaxis.
    California medicine, 1954, Volume: 81, Issue:6

    Topics: Cardiovascular Agents; Epistaxis; Hexamethonium; Hypertension; Muscle Relaxants, Central; Shock

1954
[Clinical study of hexamethonium in arterial hypertension].
    Minerva medica, 1954, Oct-10, Volume: 45, Issue:81

    Topics: Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Central

1954
Hexamethonium and apresoline (L-hydrazinophthalazine) in the treatment of malignant hypertension; report of a case.
    Rhode Island medical journal, 1954, Volume: 37, Issue:10

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypertension, Malignant; Muscle Rel

1954
[Administration of hexamethonium to patients with severe hypertension].
    L'union medicale du Canada, 1954, Volume: 83, Issue:11

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1954
Treatment of hypertension with oral reserpine alone and in combination with hydralazine or hexamethonium.
    The American journal of the medical sciences, 1955, Volume: 229, Issue:2

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypnotics and Sedatives; Muscle Rel

1955
The effect of hexamethonium upon cerebral blood flow and metabolism in patients with premalignant and malignant hypertension.
    Circulation, 1955, Volume: 11, Issue:1

    Topics: Brain; Cerebrovascular Circulation; Hexamethonium; Humans; Hypertension; Hypertension, Malignant; Mu

1955
The effects of intravenous hexamethonium on venous pressure of normotensive and hypertensive patients with and without congestive heart failure.
    Circulation, 1955, Volume: 11, Issue:2

    Topics: Blood Pressure; Blood Pressure Determination; Heart Failure; Hexamethonium; Humans; Hypertension; Ve

1955
[Effect of hexamethonium loading test on ballistocardiogram and ECG in hypertensive subjects].
    Folia cardiologica, 1954, Aug-31, Volume: 13, Issue:4

    Topics: Ballistocardiography; Cardiovascular Agents; Electrocardiography; Hexamethonium; Humans; Hypertensio

1954
Severe hypertension treated with hexamethonium bromide in retard medium.
    Lancet (London, England), 1955, Feb-18, Volume: 268, Issue:6860

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1955
[New trends in the treatment of hypertension. II. Experimental investigations on two new Hungarian preparations; hexamethonium, N. 310].
    Orvosi hetilap, 1955, Apr-24, Volume: 96, Issue:17

    Topics: Autonomic Agents; Autonomic Nervous System; Hexamethonium; Humans; Hypertension; Muscle Relaxants, C

1955
Permanent bilateral blindness following the use of hexamethonium chloride.
    A.M.A. archives of ophthalmology, 1955, Volume: 54, Issue:3

    Topics: Blindness; Hexamethonium; Hypertension; Muscle Relaxants, Central; Vision Disorders

1955
Newer drugs in the treatment of hypertension. II. Use of hexamethonium in combination with hydralazine.
    Circulation, 1955, Volume: 12, Issue:3

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho

1955
[Vectorcardiographic studies in hypertensive patients with massive blood pressure reduction by hexamethonium; contribution to the theory of ventricular gradients].
    Cardiologia, 1955, Volume: 27, Issue:3

    Topics: Blood Pressure; Hexamethonium; Humans; Hypertension; Hypotension; Muscle Relaxants, Central; Vectorc

1955
Hematuria during treatment of severe hypertension with hexamethonium bromide and pentolinium tartrate.
    The Journal of the Florida Medical Association. Florida Medical Association, 1955, Volume: 42, Issue:4

    Topics: Cardiovascular Agents; Hematuria; Hexamethonium; Hypertension; Muscle Relaxants, Central; Pentoliniu

1955
Pentolinium and hexamethonium combined with Rauwolfia in the treatment of hypertension.
    The New England journal of medicine, 1955, Oct-06, Volume: 253, Issue:14

    Topics: Antihypertensive Agents; Cardiovascular Agents; Hexamethonium; Hypertension; Hypnotics and Sedatives

1955
Methium chloride with reserpine, a new antihypertensive combination.
    New York state journal of medicine, 1955, Dec-01, Volume: 55, Issue:23

    Topics: Antihypertensive Agents; Cardiovascular Agents; Chlorides; Hexamethonium; Hypertension; Muscle Relax

1955
The effect of pentolinium on renal hemodynamics and water and electrolyte excretion: a comparison with hexamethonium.
    The American journal of the medical sciences, 1956, Volume: 231, Issue:3

    Topics: Electrolytes; Hemodynamics; Hexamethonium; Hypertension; Kidney; Muscle Relaxants, Central; Pentolin

1956
[The treatment of hypertension with hexamethonium bromide and Rauwolfia preparations].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1955, Oct-01, Volume: 10, Issue:19

    Topics: Antihypertensive Agents; Hexamethonium; Hypertension; Hypnotics and Sedatives; Muscle Relaxants, Cen

1955
[The hexamethonium in hypertensive encephalopathy].
    Anales. Universidad Nacional Mayor de San Marcos. Facultad de Medicina, 1955, Volume: 38, Issue:4

    Topics: Hexamethonium; Hypertension; Hypertensive Encephalopathy; Muscle Relaxants, Central; Vascular Diseas

1955
[Studies of the effect of small doses of hexamethonium on blood circulation in normal and hypertensive subjects].
    Cardiologia, 1956, Volume: 28, Issue:2

    Topics: Blood Circulation; Cardiovascular Agents; Hexamethonium; Humans; Hypertension; Muscle Relaxants, Cen

1956
Clinical observations on the oral use of hexamethonium, hydralazine, and rauwolfia extracts in essential hypertension.
    New York state journal of medicine, 1956, Apr-15, Volume: 56, Issue:8

    Topics: Antihypertensive Agents; Essential Hypertension; Hexamethonium; Humans; Hydralazine; Hypertension; M

1956
The effect of a ganglionic blocking agent (hexamethonium) on renal function and on excretion of water and electrolytes in hypertension and in congestive heart failure.
    American heart journal, 1956, Volume: 52, Issue:1

    Topics: Electrolytes; Ganglionic Blockers; Heart Failure; Hexamethonium; Humans; Hypertension; Kidney Functi

1956
[Prolonged treatment of essential hypertension with hexamethonium and serpasil].
    Acta medica Scandinavica. Supplementum, 1956, Volume: 312

    Topics: Antihypertensive Agents; Essential Hypertension; Hexamethonium; Hypertension; Muscle Relaxants, Cent

1956
Renal haemodynamic effects of hypotensive drugs. I. Acute effects of hexamethonium bromide before and after treatment with reserpine.
    Lancet (London, England), 1957, Jan-12, Volume: 272, Issue:6959

    Topics: Antihypertensive Agents; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension;

1957
Renal haemodynamic effects of hypotensive drugs. I. Acute effects of hexamethonium bromide before and after treatment with reserpine.
    Lancet (London, England), 1957, Jan-12, Volume: 272, Issue:6959

    Topics: Antihypertensive Agents; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension;

1957
Renal haemodynamic effects of hypotensive drugs. I. Acute effects of hexamethonium bromide before and after treatment with reserpine.
    Lancet (London, England), 1957, Jan-12, Volume: 272, Issue:6959

    Topics: Antihypertensive Agents; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension;

1957
Renal haemodynamic effects of hypotensive drugs. I. Acute effects of hexamethonium bromide before and after treatment with reserpine.
    Lancet (London, England), 1957, Jan-12, Volume: 272, Issue:6959

    Topics: Antihypertensive Agents; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension;

1957
[Rauwolfia serpentina extracts combined with hexamethonium in therapy of arterial hypertension in diabetics].
    Minerva medica, 1957, Feb-24, Volume: 48, Issue:16

    Topics: Diabetes Complications; Diabetes Mellitus; Hexamethonium; Hexamethonium Compounds; Humans; Hypertens

1957
Gastrointestinal roentgen findings due to untoward effects of hexamethonium.
    Radiology, 1957, Volume: 68, Issue:5

    Topics: Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Intestinal Obstruction; Stomach; Stoma

1957
The effect of hexamethonium upon the pulmonary vascular resistance in mitral stenosis.
    The Journal of laboratory and clinical medicine, 1957, Volume: 50, Issue:2

    Topics: Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Mitral Valve Stenosis; Vascular Diseas

1957
Hexamethonium chloride with reserpine in the treatment of severe essential hypertension.
    Angiology, 1958, Volume: 9, Issue:1

    Topics: Essential Hypertension; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Reserpine

1958
Vascular reactivity in experimental hypertension measured after hexamethonium.
    Circulation, 1958, Volume: 17, Issue:4, Part 2

    Topics: Blood Vessels; Hexamethonium; Hypertension; Nitrites; Norepinephrine

1958
Pneumonitis as a complication of hexamethonium therapy.
    Journal of chronic diseases, 1958, Volume: 7, Issue:3

    Topics: Glomerulonephritis; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Pneumonia; Vascula

1958
[Experiences with hexamethonium salts in rectal administration in hypertension].
    Wiener klinische Wochenschrift, 1958, Mar-14, Volume: 70, Issue:11

    Topics: Administration, Rectal; Hexamethonium; Hexamethonium Compounds; Hypertension; Salts

1958
[Date on the action of hexamethonium in arterial hypertension].
    Archivio per le scienze mediche, 1958, Volume: 105, Issue:5

    Topics: Hexamethonium; Hexamethonium Compounds; Hypertension; Phoeniceae

1958
Pulmonary changes associated with hexamethonium therapy.
    A.M.A. archives of internal medicine, 1959, Volume: 103, Issue:2

    Topics: Hexamethonium; Hexamethonium Compounds; Hypertension; Pneumonia

1959
Pressor effect of subcutaneous renin in dogs, and effect of reserpine, 1-hydrazinophthalazine and hexamethonium on renin hypertension.
    The American journal of physiology, 1959, Volume: 196, Issue:3

    Topics: Animals; Dogs; Endopeptidases; Hexamethonium; Hexamethonium Compounds; Hydralazine; Hydrolases; Hype

1959
[Result of treatment of arterial hypertension with hexamethonium, thalazine & other drugs].
    Revista clinica espanola, 1959, Feb-28, Volume: 72, Issue:4

    Topics: Hexamethonium; Hexamethonium Compounds; Humans; Hydralazine; Hypertension; Hypertension, Portal

1959
[Dynamics of serum protein fractions during the treatment of hypertension with Rauwolfia serpentina preparations and hexonium].
    Terapevticheskii arkhiv, 1961, Volume: 33

    Topics: Bis-Trimethylammonium Compounds; Blood Proteins; Hexamethonium; Hypertension; Rauwolfia; Serum Album

1961
Hexamethonium trial as a diagnostic test of the principal forms of arterial hypertension
    La Riforma medica, 1960, Oct-08, Volume: 74

    Topics: Diagnostic Tests, Routine; Hexamethonium; Hexamethonium Compounds; Hypertension

1960
[Treatment of patients with hypertension with hexonium and reserpine].
    Zdravookhranenie Belorussii, 1962, Volume: 8

    Topics: Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Reserpine

1962
[The treatment of hypertension by Depressin].
    Terapevticheskii arkhiv, 1962, Volume: 34

    Topics: Antihypertensive Agents; Hexamethonium; Humans; Hypertension; Imidazoles; Pentobarbital; Reserpine

1962
[Effect of Gangleron and Hexonium on regional blood circulation in patients with hypertension].
    Klinicheskaia meditsina, 1962, Volume: 40

    Topics: Ganglionic Blockers; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Plethysmography

1962
[DIFFERENTIATION BY HEXAMETHONIUM OF THE HYPERTENSIVE ACTIONS RESPECTIVELY EXERCISED BY POTASSIUM ION AND ACETYLCHOLINE].
    Comptes rendus hebdomadaires des seances de l'Academie des sciences, 1964, Feb-10, Volume: 258

    Topics: Acetylcholine; Animals; Blood Pressure; Blood Pressure Determination; Dogs; Exercise; Hexamethonium;

1964
[ON DEPRESSIN THERAPY OF PATIENTS WITH RESERPINE-RESISTANT FORMS OF HYPERTENSION].
    Sovetskaia meditsina, 1964, Volume: 27

    Topics: Antihypertensive Agents; Hexamethonium; Humans; Hypertension; Reserpine

1964
[USE OF HEXONIUM IN A POLYCLINIC].
    Klinicheskaia meditsina, 1965, Volume: 43

    Topics: Drug Therapy; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Reserpine

1965
Acute hemodynamic effects of hexamethonium (C6) in patients with emphysematous pulmonary hypertension.
    American heart journal, 1955, Volume: 49, Issue:4

    Topics: Emphysema; Hemodynamics; Hexamethonium; Humans; Hypertension; Hypertension, Pulmonary; Muscle Relaxa

1955
Pulmonary complications during treatment with hexamethonium.
    Canadian Medical Association journal, 1955, Mar-15, Volume: 72, Issue:6

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Lung; Muscle Relaxants, Central

1955
Hexamethonium, hydralazine and rauwolfia serpentina therapy in hypertension.
    The American journal of the medical sciences, 1955, Volume: 229, Issue:5

    Topics: Antihypertensive Agents; Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Rel

1955
[Combination of hexamethonium and hydrazinophthalazine in the treatment of arterial hypertension].
    L' Ospedale maggiore, 1954, Volume: 42, Issue:10

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Sympatho

1954
[Treatment of essential arterial hypertension with hexamethonium chloride].
    L'union medicale du Canada, 1955, Volume: 84, Issue:3

    Topics: Essential Hypertension; Hexamethonium; Hypertension; Muscle Relaxants, Central

1955
Oral hexamethonium in hypertension.
    Glasgow medical journal, 1955, Volume: 36, Issue:5

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1955
Cardiovascular and renal responses to the combination of hexamethonium and 1-hydrazinophthalazine (apresoline) in hypertensive subjects.
    The Journal of clinical investigation, 1955, Volume: 34, Issue:6

    Topics: Cardiovascular System; Hexamethonium; Hydralazine; Hypertension; Kidney; Muscle Relaxants, Central;

1955
[Prolonged-action hexamethonium in therapy of arterial hypertension].
    Revista brasileira de medicina, 1955, Volume: 12, Issue:2

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1955
Evaluation of drug therapy of hypertension; experience with ansolysen, hexamethonium, apresoline, and reserpine.
    New York state journal of medicine, 1955, Jul-15, Volume: 55, Issue:14

    Topics: Drug Therapy; Hexamethonium; Hydralazine; Hypertension; Pentolinium Tartrate; Reserpine

1955
Hypertension treatment with alkaloids of Veratrum viride and Veratrum album alone or in combination with hexamethonium salts.
    Acta medica Scandinavica, 1955, Volume: 151, Issue:6

    Topics: Alkaloids; Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts; Ver

1955
[Effect of hexamethonium on renal circulation and function in cardiacs and hypertensives].
    Pathologie et biologie, 1959, Volume: 7

    Topics: Heart Diseases; Hexamethonium; Hexamethonium Compounds; Humans; Hypertension; Kidney; Renal Circulat

1959
Observations on the responses of rats with spontaneous hypertension and control rats to pressor drugs and to hexamethonium.
    Circulation research, 1962, Volume: 10

    Topics: Arginine Vasopressin; Disease; Epinephrine; Hexamethonium; Hypertension; Rats; Rodent Diseases; Thio

1962
Blood pressure effects of intravenous apomorphine in conscious deoxycorticosterone-acetate salt-hypertensive rats.
    Journal of cardiovascular pharmacology, 2003, Volume: 42, Issue:6

    Topics: Animals; Apomorphine; Behavior, Animal; Blood Pressure; Desoxycorticosterone; Domperidone; Dopamine

2003
Treatment of severe hypertension with hexamethonium bromide.
    British medical journal, 1950, Oct-07, Volume: 2, Issue:4683

    Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Hexamethonium; Hypert

1950
Some results of treatment with hexamethonium bromide in cases of vascular hypertension.
    Journal of the Irish Medical Association, 1951, Volume: 28, Issue:165

    Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Hexamethonium; Hypert

1951
Hexamethonium bromide in vascular hypertension.
    Journal of the Irish Medical Association, 1951, Volume: 28, Issue:165

    Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Hexamethonium; Hypert

1951
Treatment of arterial hypertension by penta- and hexamethonium salts; based on 150 tests on hypertensives of varied aetiology and 53 patients treated for periods of two to fourteen months.
    British medical journal, 1951, Jun-02, Volume: 1, Issue:4717

    Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Hexamethonium; Hypert

1951
Veratrum viride and hexamethonium in the treatment of severe diastolic hypertension.
    The Medical annals of the District of Columbia, 1951, Volume: 20, Issue:6

    Topics: Autonomic Nervous System Diseases; Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure D

1951
Oral hexamethonium bromide in essential hypertension.
    British medical journal, 1951, Aug-04, Volume: 2, Issue:4726

    Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Essential Hypertensio

1951
Syncope during hexamethonium administration.
    Journal of the Irish Medical Association, 1951, Volume: 28, Issue:168

    Topics: Animals; Anura; Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Hexam

1951
Effect of hexamethonium bromide in arterial hypertension.
    Lancet (London, England), 1951, Sep-15, Volume: 2, Issue:6681

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1951
Treatment of hypertension with hexamethonium bromide.
    Lancet (London, England), 1951, Nov-17, Volume: 2, Issue:6690

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1951
[Hexamethonium therapy of essential hypertension].
    Ugeskrift for laeger, 1951, Oct-04, Volume: 113, Issue:40

    Topics: Essential Hypertension; Hexamethonium; Hypertension; Muscle Relaxants, Central

1951
M. & B. 1863, a homologue of hexamethonium, in treatment of hypertension.
    British medical journal, 1952, Feb-02, Volume: 1, Issue:4752

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1952
The treatment of hypertension with hexamethonium.
    Circulation, 1952, Volume: 5, Issue:1

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1952
[Hexamethonium bromide in hypertension therapy].
    Nordisk medicin, 1951, Oct-17, Volume: 46, Issue:42

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1951
Control of hypertension by hexamethonium and 1-hydrazinophthalazine; preliminary observations.
    A.M.A. archives of internal medicine, 1952, Volume: 89, Issue:4

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central

1952
Comparison of the effects of veratrum alkaloids and of hexamethonium bromide upon the blood pressure in arterial hypertension.
    American heart journal, 1952, Volume: 43, Issue:4

    Topics: Blood Pressure; Blood Pressure Determination; Cardiovascular Agents; Hexamethonium; Humans; Hyperten

1952
Clinical evaluation of 1-hydrazinophthalazine (C-5968) in hypertension, with special reference to alternating treatment with hexamethonium.
    Circulation, 1952, Volume: 5, Issue:6

    Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central

1952
Some observations on the use of hexamethonium bromide in the treatment of ambulant hypertensives.
    The Medical journal of Australia, 1952, May-24, Volume: 1, Issue:21

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1952
Treatment of hypertension; results with hexamethonium salts administered orally.
    Texas state journal of medicine, 1952, Volume: 48, Issue:6

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts

1952
[Hexamethonium salts in hypertension].
    Pharmaceutisch weekblad, 1952, Mar-15, Volume: 87, Issue:11-12

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central; Salts

1952
[Action on hexamethonium bromide on arterial hypertension].
    Prensa medica argentina, 1952, May-16, Volume: 39, Issue:20

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1952
NEW approved drugs: hexamethonium bromide; hydralazine hydrochloride.
    Medical bulletin (Ann Arbor, Mich.), 1952, Volume: 18, Issue:6

    Topics: Drug Approval; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central

1952
[Hexamethonium therapy of arterial hypertension].
    Arquivos brasileiros de cardiologia, 1952, Volume: 5, Issue:1

    Topics: Cardiovascular Agents; Hexamethonium; Hypertension; Muscle Relaxants, Central

1952
[Penta- and hexamethonium in arterial hypertension].
    Giornale di clinica medica, 1952, Volume: 33, Issue:3

    Topics: Hexamethonium; Hypertension; Muscle Relaxants, Central; Oligosaccharides; Rubiaceae

1952
Pentamethonium and hexamethonium iodide in investigation of peripheral vascular disease and hypertension.
    British medical journal, 1950, Feb-25, Volume: 1, Issue:4651

    Topics: Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure Determination; Blood Vessels; Hexame

1950
The treatment of high blood pressure with hexamethonium iodide.
    The New Zealand medical journal, 1950, Volume: 49, Issue:271

    Topics: Blood Pressure; Blood Pressure Determination; Hexamethonium; Hypertension; Iodine; Iodine Isotopes

1950
Contribution of the subfornical organ to angiotensin II-induced hypertension.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:2

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Drinking; Heart Rate; Hexamethoniu

2005
Sex differences in the development of angiotensin II-induced hypertension in conscious mice.
    American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:5

    Topics: Angiotensin II; Animals; Baroreflex; Blood Pressure; Consciousness; Female; Ganglionic Blockers; Hea

2005
Contribution of central nitric oxide to the regulation of blood pressure and sodium balance in DOCA-salt hypertension.
    Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:5

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Desoxycorticosterone; Drinking; Eating; Enzyme Inhibi

2006
Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:4

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Brain; Car

2006
Exercise pressor reflex function is altered in spontaneously hypertensive rats.
    The Journal of physiology, 2006, Dec-15, Volume: 577, Issue:Pt 3

    Topics: Animals; Arteries; Baroreflex; Blood Pressure; Echocardiography; Electric Stimulation; Ganglionic Bl

2006
Increased sympathetic activity in rats submitted to chronic intermittent hypoxia.
    Experimental physiology, 2007, Volume: 92, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Chronic Disease; Disease Models, A

2007
Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    American journal of hypertension, 2007, Volume: 20, Issue:6

    Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Blood Pressure; Body Weight; Captop

2007
Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Clinical and experimental pharmacology & physiology, 2007, Volume: 34, Issue:7

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Arginine Vasopressin; Baroreflex; Blood Glucose; B

2007
Acute antihypertensive action of Tempol in the spontaneously hypertensive rat.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:6

    Topics: Amitrole; Animals; Antihypertensive Agents; Blood Pressure; Buthionine Sulfoximine; Catalase; Cromak

2007
Effect of peripheral sympathetic nerve dysfunction on salt sensitivity of arterial pressure.
    Clinical and experimental pharmacology & physiology, 2008, Volume: 35, Issue:3

    Topics: Animals; Antihypertensive Agents; Autonomic Nervous System Diseases; Blood Pressure; Dose-Response R

2008
Hyperinsulinemic rats are normotensive but sensitized to angiotensin II.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 294, Issue:4

    Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Ag

2008
Post-resistance exercise hypotension in spontaneously hypertensive rats is mediated by nitric oxide.
    Clinical and experimental pharmacology & physiology, 2008, Volume: 35, Issue:7

    Topics: Animals; Blood Pressure; Hexamethonium; Hypertension; Hypotension; Male; NG-Nitroarginine Methyl Est

2008
Preload and afterload reduction in treating congestive heart failure.
    Journal of cardiovascular pharmacology, 1984, Volume: 6 Suppl 6

    Topics: Autonomic Nerve Block; Heart Failure; Hemodynamics; Hexamethonium; Hexamethonium Compounds; Humans;

1984
Factors influencing the altered pain perception in the spontaneously hypertensive rat.
    Brain research, 1982, Apr-08, Volume: 237, Issue:1

    Topics: Animals; Blood Pressure; Heart Rate; Hexamethonium; Hexamethonium Compounds; Hypertension; Male; Mus

1982
GABA receptor binding and hemodynamic responses to ICV GABA in adult spontaneously hypertensive rats.
    Life sciences, 1983, Aug-22, Volume: 33, Issue:8

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain; gamma-Aminobutyric Acid; Heart Rate; Hemody

1983
[Combined treatment of hypertension patients].
    Vrachebnoe delo, 1984, Issue:10

    Topics: Adolescent; Adult; Antihypertensive Agents; Clonidine; Drug Combinations; Drug Evaluation; Drug Ther

1984
Contribution of vasopressin to hypertension after solitary tract lesioning in the dog.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1984, Volume: 2, Issue:3

    Topics: Acute Disease; Animals; Arginine Vasopressin; Blood Pressure; Dogs; Heart Rate; Hexamethonium; Hexam

1984
Effect of methylguanidine on rat blood pressure: role of endothelial nitric oxide synthase.
    British journal of pharmacology, 1995, Volume: 115, Issue:3

    Topics: Animals; Arginine; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Endothe

1995
Contribution of alpha- and beta- adrenoceptors and neuropeptide-Y to autonomic dysreflexia.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1995, Volume: 5, Issue:2

    Topics: Animals; Autonomic Nervous System Diseases; Blood Pressure; Ganglionic Blockers; Heart Rate; Hexamet

1995
Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs.
    Hypertension (Dallas, Tex. : 1979), 1993, Volume: 21, Issue:1

    Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Dogs; Female; Heart Rate; Hexamethoni

1993
Antihypertensive effect of taurine on salt-induced hypertension.
    Advances in experimental medicine and biology, 1994, Volume: 359

    Topics: Animals; Blood Pressure; Brain; Hexamethonium; Hypertension; Hypothalamus; Injections, Intraventricu

1994
Arterial hypertrophy and pressor responsiveness during development of hypertension in spontaneously hypertensive rats.
    Journal of hypertension, 1994, Volume: 12, Issue:1

    Topics: Animals; Blood Pressure; Ganglionic Blockers; Heart Ventricles; Hemodynamics; Hexamethonium; Hexamet

1994
Involvement of the sympathetic nervous system in antihypertensive effect of cicletanine in salt-loaded young spontaneously hypertensive rats.
    American journal of hypertension, 1994, Volume: 7, Issue:6

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Dopamine; Hexamethonium; Hypertension; Male; Norep

1994
Excitatory amino acid receptors in the rostral ventrolateral medulla mediate hypertension induced by carotid body chemoreceptor stimulation.
    Naunyn-Schmiedeberg's archives of pharmacology, 1994, Volume: 349, Issue:6

    Topics: Animals; Blood Pressure; Carotid Body; Cordotomy; Excitatory Amino Acid Antagonists; Heart Rate; Hex

1994
Study of the hemodynamic contributing factors of spontaneously hypertensive rats in the early stage of established hypertension.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1993, Volume: 15, Issue:1

    Topics: Animals; Blood Pressure; Cardiac Output; Cerebrovascular Disorders; Hemodynamics; Hexamethonium; Hex

1993
Contribution of the sympathetic nervous system to salt-sensitivity in lifetime captopril-treated spontaneously hypertensive rats.
    Journal of hypertension, 1995, Volume: 13, Issue:9

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Clonidine; Hexamethonium; Hypertension;

1995
Parasympathetic component of 5-hydroxytryptamine-induced pulmonary dysfunctions in healthy calves.
    American journal of veterinary research, 1996, Volume: 57, Issue:6

    Topics: Aging; Animals; Apnea; Atropine; Bradycardia; Cattle; Cattle Diseases; Cholinergic Agents; Ganglioni

1996
Central GABAergic mechanisms are defective in salt-induced hypertension in borderline hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 1995, Volume: 18, Issue:4

    Topics: Animals; Antihypertensive Agents; Bicuculline; Blood Pressure; Consciousness; GABA Antagonists; gamm

1995
Contribution of the sympathetic nervous system to hypertensive response to insulin excess in spontaneously hypertensive rats.
    Journal of cardiovascular pharmacology, 1996, Volume: 27, Issue:4

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Clonidine; Ganglion

1996
Tachyphylaxis and sensitization to nicotine-induced tachycardiac and pressor effects after nicotine infusions.
    Archives of medical research, 1997,Summer, Volume: 28, Issue:2

    Topics: Animals; Blood Pressure; Bradycardia; Decerebrate State; Drug Administration Schedule; Ganglionic Bl

1997
Autonomic control of ultradian and circadian rhythms of blood pressure, heart rate, and baroreflex sensitivity in spontaneously hypertensive rats.
    Journal of hypertension, 1997, Volume: 15, Issue:4

    Topics: Adrenergic alpha-Antagonists; Animals; Autonomic Nervous System; Blood Pressure; Circadian Rhythm; H

1997
Reduction of insulin resistance attenuates the development of hypertension in sucrose-fed SHR.
    Life sciences, 1997, Volume: 61, Issue:4

    Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Catecholamines; Dietary

1997
Sympathetic nervous system and hypertension during prolonged TxA2/PGH2 receptor activation in rats.
    The American journal of physiology, 1997, Volume: 273, Issue:2 Pt 2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Antihypertensive Agents

1997
Food restriction attenuates the blood pressure response to paraventricular hypothalamic nuclei lesions in aortic coarctation hypertension.
    Brain research, 1998, May-11, Volume: 792, Issue:2

    Topics: Adrenergic alpha-Agonists; Animals; Aortic Coarctation; Atropine; Blood Glucose; Blood Pressure; Bod

1998
Dietary-sodium-induced cardiac remodeling in spontaneously hypertensive rat versus Wistar-Kyoto rat.
    Journal of hypertension, 1998, Volume: 16, Issue:6

    Topics: Angiotensin II; Animals; Blood Pressure; Catecholamines; Ganglionic Blockers; Heart Rate; Heart Vent

1998
Nitric oxide dependent vasodilation in young spontaneously hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 1998, Volume: 32, Issue:4

    Topics: Aging; Animals; Antihypertensive Agents; Blood Pressure; Drug Interactions; Enzyme Inhibitors; Hexam

1998
Attenuation of cardiac but not vascular component in baroreflex of spontaneously hypertensive rats.
    The Chinese journal of physiology, 1998, Jun-30, Volume: 41, Issue:2

    Topics: Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Atropine; Baroreflex; Blood Pressure; B

1998
The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes.
    Circulation research, 1998, Nov-16, Volume: 83, Issue:10

    Topics: Angiotensins; Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Brain Chemistr

1998
Daily exercise enhances acetylcholine-induced dilation in mesenteric and hindlimb vasculature of hypertensive rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1999, Volume: 21, Issue:4

    Topics: Acetylcholine; Animals; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Follow-Up Studies;

1999
Role of cholinergic receptors in adrenal catecholamine secretion in spontaneously hypertensive rats.
    The American journal of physiology, 1999, Volume: 277, Issue:4

    Topics: Adrenal Glands; Animals; Atropine; Electric Stimulation; Epinephrine; Hexamethonium; Hypertension; I

1999
The pharmacological effects of an aqueous extract from Acacia nilotica seeds.
    Phytotherapy research : PTR, 1999, Volume: 13, Issue:8

    Topics: Acacia; Acetylcholine; Animals; Atropine; Blood Pressure; Cats; Dose-Response Relationship, Drug; Gu

1999
Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Glucose; B

2000
Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2

    Topics: Animals; Atrasentan; Blood Volume; Consciousness; Desoxycorticosterone; Endothelin Receptor Antagoni

2000
Right ventricular pressure and dilation during pressure overload determine dysfunction after pressure overload.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 278, Issue:5

    Topics: Animals; Atropine; Cardiac Catheterization; Cardiotonic Agents; Cardiovascular Agents; Diastole; Dil

2000
Pathophysiological role of leptin in obesity-related hypertension.
    The Journal of clinical investigation, 2000, Volume: 105, Issue:9

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; alpha-MSH; Animals; Blood Pressure; Body

2000
Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:2

    Topics: Angiotensin Receptor Antagonists; Angiotensins; Animals; Antihypertensive Agents; Benzimidazoles; Bi

2000
Inhibition of abnormal hindquarter vascular tone in spontaneously hypertensive rats with chlorpromazine.
    The Tohoku journal of experimental medicine, 2000, Volume: 192, Issue:1

    Topics: Animals; Chlorpromazine; Drug Administration Schedule; Female; Ganglionic Blockers; Hexamethonium; H

2000
Control of renin secretion from adrenal gland in transgenic Ren-2 and normal rats.
    Molecular and cellular endocrinology, 2001, Feb-28, Volume: 173, Issue:1-2

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitor

2001
Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
    Journal of hypertension, 2001, Volume: 19, Issue:3

    Topics: Animals; Blood Pressure; Desoxycorticosterone; Endothelin Receptor Antagonists; Endothelin-1; Hemody

2001
Contribution of central amiloride-sensitive transport systems to the development of hypertension in spontaneously hypertensive rats.
    Brain research, 2001, Jul-06, Volume: 906, Issue:1-2

    Topics: Amiloride; Angiotensin II; Animals; Blood Pressure; Body Weight; Brain; Carrier Proteins; Diuretics;

2001
Is clinical research still too haphazard.
    Lancet (London, England), 2001, Nov-10, Volume: 358, Issue:9293

    Topics: Antihypertensive Agents; Biomedical Research; Clinical Trials as Topic; Hexamethonium; Humans; Hyper

2001
Contribution of endogenous vasopressin to regional hemodynamics in borderline-hypertensive Hiroshima rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2002, Volume: 25, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Argini

2002
Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:1

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Attention Deficit Disorder with Hyperactivity; Beh

2002
History of research into hypertension.
    Journal of the Royal Society of Medicine, 1992, Volume: 85, Issue:8

    Topics: Bretylium Compounds; Ganglionic Blockers; Hexamethonium; Hexamethonium Compounds; History, 20th Cent

1992
Role of the sympathetic nervous system in the alcohol-guanabenz hemodynamic interaction.
    Canadian journal of physiology and pharmacology, 1992, Volume: 70, Issue:9

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Catecholamines; Dose-Response Relationship, Drug;

1992
Blockade of acute hypertensive response does not prevent changes in behavior or in CSF acetylcholine (ACH) content following traumatic brain injury (TBI).
    Brain research, 1992, Apr-03, Volume: 576, Issue:2

    Topics: Acetylcholine; Analysis of Variance; Animals; Axonal Transport; Behavior, Animal; Blood Pressure; Br

1992
Hexamethonium and midazolam terminate dysrhythmias and hypertension caused by intracerebroventricular bupivacaine in rabbits.
    Anesthesiology, 1991, Volume: 74, Issue:1

    Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Brain; Bupivacaine; Halotha

1991
Lateral parabrachial nucleus and angiotensin II-induced hypertension.
    Hypertension (Dallas, Tex. : 1979), 1991, Volume: 17, Issue:6 Pt 2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Blood Pressure; Gan

1991
Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area.
    European journal of pharmacology, 1991, Jan-17, Volume: 192, Issue:3

    Topics: Animals; Blood Pressure; Cats; Cyproheptadine; Female; Heart Rate; Hexamethonium; Hexamethonium Comp

1991
Autoregulatory capacity in renal and mesenteric vasculatures of mineralocorticoid hypertensive dogs.
    The American journal of physiology, 1991, Volume: 261, Issue:4 Pt 2

    Topics: Adenosine; Animals; Blood Pressure; Desoxycorticosterone; Dogs; Female; Ganglionic Blockers; Hexamet

1991
Suppression of the renin-angiotensin system induced by streptozotocin treatment in neonatal spontaneously hypertensive rats.
    Japanese circulation journal, 1990, Volume: 54, Issue:2

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Diabetes Mellitus, Experim

1990
Further evidence for abnormal hindquarter tone in spontaneously hypertensive rats.
    The Japanese journal of physiology, 1990, Volume: 40, Issue:4

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Ganglia, Sympathetic; Ganglionic Blockers; Hexamethon

1990
Role of afferent renal nerves in spontaneous hypertension in rats.
    Hypertension (Dallas, Tex. : 1979), 1989, Volume: 13, Issue:4

    Topics: Afferent Pathways; Animals; Female; Ganglia, Spinal; Ganglionectomy; Hexamethonium; Hexamethonium Co

1989
Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
    American journal of hypertension, 1989, Volume: 2, Issue:8

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Desoxycorticosterone; Epinephrine; Hexamethonium; Hex

1989
Contribution of the baroreflex afferent nerves to the production of vasoconstricted hypertension in volume-expanded dogs.
    Circulation research, 1989, Volume: 65, Issue:6

    Topics: Afferent Pathways; Animals; Blood Pressure; Blood Volume; Diuresis; Dogs; Hemodynamics; Hexamethoniu

1989
Role of autonomic nervous system on heart rate in experimental hypertension.
    Revista espanola de fisiologia, 1985, Volume: 41, Issue:1

    Topics: Animals; Atropine; Autonomic Nervous System; Heart Conduction System; Heart Rate; Hemicholinium 3; H

1985
Chronic salt loading and central adrenergic mechanisms in the spontaneously hypertensive rat.
    Acta pharmacologica et toxicologica, 1985, Volume: 56, Issue:3

    Topics: Animals; Blood Pressure; Central Nervous System; Clonidine; Dopamine; Heart Rate; Hexamethonium; Hex

1985
Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
    The American journal of physiology, 1985, Volume: 249, Issue:1 Pt 2

    Topics: Adrenal Medulla; Animals; Blood Pressure; Bromocriptine; Depression, Chemical; Desoxycorticosterone;

1985
Neurohumoral contributions to chronic angiotensin-induced hypertension.
    The American journal of physiology, 1986, Volume: 250, Issue:1 Pt 2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Blood Pressure; Blo

1986
[Effect of depression and dopegit on regional blood flow in patients with hypertension].
    Vrachebnoe delo, 1986, Issue:3

    Topics: Adult; Aged; Antihypertensive Agents; Blood Circulation; Female; Hexamethonium; Hexamethonium Compou

1986
The adrenergic nervous control of fluid transport in the small intestine of normotensive and spontaneously hypertensive rats.
    Acta physiologica Scandinavica, 1986, Volume: 126, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adrenergic Fibers; Animals; Blood Pressure; Electric Stimulation; Hexa

1986
The role of the sympathetic nervous system in 2-kidney DOCA-hypertensive Yucatan miniature swine.
    Clinical and experimental hypertension. Part A, Theory and practice, 1986, Volume: 8, Issue:3

    Topics: Animals; Blood Pressure; Cardiac Output; Catecholamines; Desoxycorticosterone; Female; Heart Rate; H

1986
Brain renin angiotensin system contributes to the salt-induced enhancement of hypertension in SHR.
    Clinical and experimental hypertension. Part A, Theory and practice, 1986, Volume: 8, Issue:7

    Topics: Angiotensin II; Animals; Blood Pressure; Brain; Captopril; Dose-Response Relationship, Drug; Hexamet

1986
Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
    Hypertension (Dallas, Tex. : 1979), 1987, Volume: 9, Issue:1

    Topics: Animals; Blood Pressure; Cold Temperature; Desoxycorticosterone; Hexamethonium; Hexamethonium Compou

1987
[Changes in the sensitivity of cardiovascular beta adrenergic receptors after sinoaortic denervation in rats].
    Medicina, 1986, Volume: 46, Issue:2

    Topics: Animals; Blood Pressure; Denervation; Female; Hexamethonium; Hexamethonium Compounds; Hypertension;

1986
Dietary sodium restriction, blood pressure and sympathetic activity in spontaneously hypertensive rats.
    Journal of hypertension, 1987, Volume: 5, Issue:1

    Topics: Animals; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Epinephrine; Ganglia, Sympathetic; He

1987
The area postrema in deoxycorticosterone-salt hypertension in rats.
    Hypertension (Dallas, Tex. : 1979), 1987, Volume: 9, Issue:6 Pt 2

    Topics: Animals; Blood Pressure; Body Water; Cerebral Ventricles; Desoxycorticosterone; Ganglionic Blockers;

1987
Prevention of hypertension and maintenance of normotension in spontaneously hypertensive rats is dependent on continuous severe dietary sodium restriction.
    Canadian journal of physiology and pharmacology, 1987, Volume: 65, Issue:4

    Topics: Aging; Animals; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Eating; Hexamethonium; Hexamet

1987
Dietary sodium intake and age in spontaneously hypertensive rats: effects on blood pressure and sympathetic activity.
    Life sciences, 1987, Aug-10, Volume: 41, Issue:6

    Topics: Aging; Animals; Blood Pressure; Body Weight; Catecholamines; Diet, Sodium-Restricted; Growth Disorde

1987
Balance among autonomic controls of heart rate in neonatal spontaneously hypertensive and borderline hypertensive rats.
    Journal of the autonomic nervous system, 1988, Volume: 22, Issue:1

    Topics: Age Factors; Animals; Animals, Newborn; Antihypertensive Agents; Atenolol; Atropine Derivatives; Aut

1988
Ontogeny of blood pressure in the inbred Dahl hypertension-sensitive and -resistant rat.
    American journal of hypertension, 1988, Volume: 1, Issue:3 Pt 3

    Topics: Animals; Blood Pressure; Desoxycorticosterone; Hexamethonium; Hexamethonium Compounds; Hypertension;

1988